Shaping the Microglia in Retinal Degenerative Diseases Using Stem Cell Therapy: Practice and Prospects

被引：8
|
作者：
Jin, Ni [1 ,2 ,3 ]
Sha, Weiwei [2 ,3 ]
Gao, Lixiong [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 3, Dept Ophthalmol, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Dept Endocrinol, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China
来源：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
关键词：
microglia; stem cell therapy; retinal degenerative disease; microglial polarization; retinal inflammation; MACULAR DEGENERATION; IN-VITRO; PIGMENT EPITHELIUM; DIRECTED DIFFERENTIATION; EXTRACELLULAR VESICLES; NEUROTROPHIC FACTORS; ACTIVATED MICROGLIA; GANGLION-CELLS; MOUSE MODEL; EXPRESSION;
D O I：
10.3389/fcell.2021.741368
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Retinal degenerative disease (RDD) refers to a group of diseases with retinal degeneration that cause vision loss and affect people's daily lives. Various therapies have been proposed, among which stem cell therapy (SCT) holds great promise for the treatment of RDDs. Microglia are immune cells in the retina that have two activation phenotypes, namely, pro-inflammatory M1 and anti-inflammatory M2 phenotypes. These cells play an important role in the pathological progression of RDDs, especially in terms of retinal inflammation. Recent studies have extensively investigated the therapeutic potential of stem cell therapy in treating RDDs, including the immunomodulatory effects targeting microglia. In this review, we substantially summarized the characteristics of RDDs and microglia, discussed the microglial changes and phenotypic transformation of M1 microglia to M2 microglia after SCT, and proposed future directions for SCT in treating RDDs.
引用
收藏
页数：17
相关论文
共 50 条
  • [31] Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future
    Mingyue Luo
    Youxin Chen
    International Journal of Ophthalmology, 2018, 11 (01) : 150 - 159
  • [32] A hydrogel-based stem cell delivery system to treat retinal degenerative diseases
    Ballios, Brian G.
    Cooke, Michael J.
    van der Kooy, Derek
    Shoichet, Molly S.
    BIOMATERIALS, 2010, 31 (09) : 2555 - 2564
  • [33] Human induced pluripotent stem cell-derived retinal organoids and their potential for stem cell-based therapies for retinal degenerative diseases
    Soler, Valeria Canto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
    Ricardo Usategui-Martín
    Ivan Fernandez-Bueno
    Neural Regeneration Research, 2021, 16 (01) : 117 - 118
  • [35] Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases
    Maeda, Akiko
    Mandai, Michiko
    Takahashi, Masayo
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 20, 2019, 2019, 20 : 201 - 216
  • [36] Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
    Usategui-Martin, Ricardo
    Fernandez-Bueno, Ivan
    NEURAL REGENERATION RESEARCH, 2021, 16 (01) : 117 - 118
  • [37] Trophic factors in the pathogenesis and therapy for retinal degenerative diseases
    Kolomeyer, Anton M.
    Zarbin, Marco A.
    SURVEY OF OPHTHALMOLOGY, 2014, 59 (02) : 134 - 165
  • [38] Retinal Degenerative Diseases Mechanisms and Experimental Therapy Preface
    Ash, John D.
    Anderson, Robert E.
    LaVail, Matthew M.
    Rickman, Catherine Bowes
    Hollyfield, Joe G.
    Grimm, Christian
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 : IX - X
  • [39] Gene therapy in inherited retinal degenerative diseases, a review
    Takahashi, Vitor K. L.
    Takiuti, Julia T.
    Jauregui, Ruben
    Tsang, Stephen H.
    OPHTHALMIC GENETICS, 2018, 39 (05) : 560 - 568
  • [40] Retinal diseases and prospects for therapy in the genomic era
    Lotery, Andrew J.
    ACTA OPHTHALMOLOGICA, 2019, 97
12345